Comparison of Low-Molecular-Weight Heparin and Warfarin for the Secondary Prevention of Venous Thromboembolism in Patients With Cancer
- 12 August 2002
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 162 (15), 1729-1735
- https://doi.org/10.1001/archinte.162.15.1729
Abstract
Research from JAMA Internal Medicine — Comparison of Low-Molecular-Weight Heparin and Warfarin for the Secondary Prevention of Venous Thromboembolism in Patients With Cancer — A Randomized Controlled StudyThis publication has 12 references indexed in Scilit:
- Prognosis of Cancers Associated with Venous ThromboembolismThe New England Journal of Medicine, 2000
- Incidence of Recurrent Thromboembolic and Bleeding Complications Among Patients With Venous Thromboembolism in Relation to Both Malignancy and Achieved International Normalized Ratio: A Retrospective AnalysisJournal of Clinical Oncology, 2000
- Should Patients with Venous Thromboembolism and Cancer Be Treated Differently?Pathophysiology of Haemostasis and Thrombosis, 1999
- Major bleeding after hospitalization for deep-venous thrombosisAmerican Journal Of Medicine, 1999
- Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous ThrombosisAnnals of Internal Medicine, 1999
- Prediction of the Risk of Bleeding During Anticoagulant Treatment for Venous ThromboembolismArchives of Internal Medicine, 1999
- Do Heparins Do More than Just Treat Thrombosis? The Influence of Heparins on Cancer SpreadThrombosis and Haemostasis, 1999
- Cancer-related thromboembolic disease in patients with solid tumours: A retrospective analysisAnnals of Oncology, 1997
- Bleeding and Thromboembolism During Anticoagulant Therapy:A Population-Based Study in Rochester, MinnesotaMayo Clinic Proceedings, 1995
- Therapeutic and clinical course of deep vein thrombosisThe American Journal of Surgery, 1983